A reasonably precise, reproducible, and sensitive microbiological procedure for directly assaying sulfacytine and other sulfonamides as antibacterially active drugs has been developed by appropriately modifying the standard disc-agar diffusion technique. Blood and urine levels as low as 3 m2g/ml may be determined through the use of a strain of Escherichia coli and a chemically defined agar medium devoid of sulfonamide antagonists. Results indicate that this assay method should be a useful adjunct to the Bratton-Marshall colorimetric procedure, by permitting the direct measurement of antibacterially active drug in clinical specimens.
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Sulfacytine (l-ethyl-N-sulfanilylcytosine) is a highly soluble, "short acting" sulfonamide (7, 9) . To study its distribution in normal volunteers, it was important to determine the proportion of active (free) sulfacytine present in blood and urine. Classically, this has been accomplished by the Bratton-Marshall (6) colorimetric procedure in which only the nonacetylated, presumably antibacterially active sulfonamide is measured as directly reacting diazotizable amine. However, this method is incapable of eliminating conjugates such as glucuronides and ethereal sulfates, which react as free sulfonamides, although they may be significantly less active antimicrobially than the nonmetabolized compound and should be determined separately (13, 16, 18) . Consideration was given to the development of a microbiological assay which would only respond to antibacterially active forms of sulfonamide. The frequently used broth dilution method was not used since it provides only a rough estimate of the concentration of antibacterially active sulfonamide in the sample (3, 11, 12, 14, 16, 22) . Although a generally parallel relationship has been demonstrated between colorimetric and broth dilution data, individual values are frequently widely divergent. The turbidimetric growth-inhibition method (1) possesses quantitative potential, but its application would be impractical because specimens need to be sterile and the assay range is narrow. Therefore, the well-known disc diffusion antibiotic assay procedure (10) was investigated as a method for determining concentration of various sulfonamides in clinical specimens.
MATERIALS AND METHODS
The assay organism was E. coli Vogel, a human clinical isolate (8) which has been maintained in lyophilized form and by transfer on Trypticase soy agar slants. Cultures were grown in a chemically defined "synthetic" liquid medium (SLM) with the following composition: asparagine, 1.0 g; Na2HPO4. 12H20, 6 .3 g; KH2PO4, 1.0 g; sodium citrate, 1.5 g; MgSO4.
7H20, 0.2 g; glycerine, 20 ml; and distilled water, 1 liter. The solution was adjusted to pH 6.6 to 6.8 and sterilized by autoclaving for 20 min at 15 psi at 121 C. All incubations were at 37 C for 16 to Aqueous stock solutions of 1,000 yg/ml were made with 1 ml of dimethylacetamide as the initial autosterilizing solvent for each 50 ml. Subsequent stock solutions (500 to 31.25 /Ag/ml) were made by serial twofold dilution. Reference standard solutions (100 to 3.125 ,4g/ml) were prepared as tenfold dilutions of the stock solutions into the appropriate vehicle. Pooled, normal human serum was the diluent for standard solutions and clinical samples in assays of human sera or human plasma. For urine assays, 0.01 M (pH 7.2), phosphate-buffered saline (PBS) was used.
Standard solutions or appropriately diluted clinical specimens were pipetted as 0.08 ml to paper assay discs (12.7 mm; no. 740-E; Schleicher and Schuell Co., Keene, N.H.) concurrent with their application to the seeded agar. The reference standard solutions were tested together on each of the four plates, the maximum number removed from the refrigerator at one time, as were each five or six appropriately diluted clinical samples and the internal plate control (12.5 ,lg/ml). Immediately after completion, the plates were inverted and incubated.
Inhibition zone diameters were measured by caliper to the nearest 0.1 mm when light, confluent background growth first appeared, usually after 16 to 20 hr of incubation. Visualization was facilitated by using a black background and oblique transmitted light in a darkened room. The light background growth precluded the use of commercial zone readers. Zone diameters on each plate containing clinical samples were corrected by adding a factor representing the difference between the internal plate control and the mean zone diameter, produced by the same solution on the standard curve plates. The concentration in the standards were plotted on the logarithmic scale of semilog graph paper against inhibition zone diameters mathematically derived from observed data, by using the least means square equation (2) . The mean corrected inhibition zone diameters obtained with the appropriately diluted clinical specimens were converted to sulfonamide concentrations (gg/ml) by reference to this semilog plot.
Influence of inoculum size and incubation time on inhibition zones. Solutions of 10, 30, and 100 ,ug of sulfacytine per ml in PBS were tested on seed layers containing 300-fold (3 X 106 CFU/ml), 1,000-fold (106 CFU/ml), and 3,000-fold (3 X 105 CFU/ml) dilutions of the standardized inoculum. Inhibition zones were observed and measured after 16, 18, 21 , and 24 hr of incubation.
Comparison of within-plate and between-plate variation of inhibition zone diameters. A PBS solution of sulfacytine (12.5 ,ug/ml) was tested at seven locations on each of seven plates. The zone diameters were subjected to analysis of variance (21) for between-plate and within-plate variations.
Application to various sulfonamides. Sulfacytine, sulfadiazine, sulfamethizole, sulfisoxazole, and sulfamethoxypyridazine were compared with respect to regression coefficients (2) and the lowest useful concentration providing a linear response. To determine whether the sulfacytine slope was significantly different from the slopes produced by the other sulfonamides, the t test (2) was used.
Sulfacytine regression lines in various diluents. Several concentrations of sulfacytine were compared in PBS, undiluted human urine, 1 and 10% human urine in PBS, undiluted human serum, undiluted human plasma, and an equal mixture of undiluted human serum and plasma. Slopes obtained at the standard reference concentrations were compared by the t test (2).
Degree of accuracy and precision. Unknown PBS or urine solutions of sulfacytine were assayed in replicate before their concentrations were revealed. The data from each run were evaluated for deviations from the mean assay value and actual content. Replicate assays were also performed on urine samples from three subjects who had received oral doses of sulfacytine. These data were evaluated for 95%/0 confidence limits of the mean and per cent deviation of each assay value from the mean (2).
RESULTS AND DISCUSSION
The synthetic media are suitable for agar diffusion sulfonamide assays since they are free of antagonists, which are contained in ordinary culture media (15, 24) , and yet support good growth of the assay organism. The Vogel strain (7) . Sharply defined, easily measured inhibition zones were obtained by carefully following the described assay procedure. Prolonged incubation times and excessively heavy inocula yielded inhibition zones with diffuse, ragged, and poorly defined perimeters, precluding accurate diameter measurements, and (Fig. 1) (2) .
That other sulfonamides may be assayed by this same procedure is exemplified by the data summarized in Table 2 , although a separate standard curve must be constructed for each sulfonamide. Variations in lowest useful concentrations and regression coefficients may reflect differences in solubility, intrinsic antibacterial activities (7, 9) , degrees of diffusion through the agar medium (4), or susceptibility to sulfonamide anatagonists in the clinical specimens (20, 23) . These considerations preclude the application of this technique to the assay of body fluids from individuals receiving multisulfonamide dosing.i
Typical regressior. equations obtained with sulfacytine in various diluents are summarized in Table 3 . At the sulfacytine concentrations employed in the assay standards, no significant differences between regression equations occurred in PBS, undiluted human urine, and their combinations. Also superimposable were the standard curves in undiluted human plasma, undiluted human serum, and a mixture of both. With low concentrations of sulfacytine, inhibition zone diameters were markedly influenced by the diluent as illustrated in Fig. 3 . In undiluted human serum, no inhibition zone was produced by 2 ,ug or less of sulfacytine per ml. This possibly resulted from protein binding (19) or the presence of sulfonamide antagonists (5, 15) .
Low concentrations of sulfacytine produced larger inhibition zones when dissolved in undiluted urine than in PBS. Urine may have enhanced the diffusion or the activity of the sulfonamide, or both (17) . This diluent-associated variation, however, would not be expected to influence the assay since much higher sulfacytine levels would be encountered at the recommended clinical dosages.
The results of replicate microbiological assays of "unknown" samples (Table 4) indicate that this procedure provides a reproducible and accurate measure of sulfacytine concentrations. In 36 replicate assays, deviations from the mean exceeded 10% in only three instances and exceeded 5% in 12 assays. Deviations from the actual value were greater than 10%VC on only four occasions.
Results of repeated assays of clinically derived urine samples are summarized in Table 5 . Deviaations from the mean varied from 0.6 to 21.3%, with the majority between 10 to 20% on either side of the mean. In only one instance was the deviation from the mean greater than 20%/C.
These data indicate that the microbiological assay procedure described herein should be a useful adjunct to the Bratton-Marshall (6) colorimetric method to determine antibacterially active concentrations of sulfacytine and other sulfonamides in clinical specimens. 
